Author:
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 282 | 99 | 3 |
Full Text Views | 6 | 1 | 0 |
PDF Downloads | 2 | 1 | 0 |
The radical curative efficacy of the 5-day primaquine regimen for vivax malaria was assessed in nonimmune volunteers infected with a West Pakistan strain of Plasmodium vivax. Treatment of each primary attack was with chloroquine, 1,500 mg base followed by primaquine, 15 mg base daily for 5 consecutive days. There was a 100% failure rate of radical cure for the 5-day primaquine regimen. Data on the pattern of relapse activity for this strain are included.
Formerly Head, Section on Primate Malaria, Laboratory of Parasitic Diseases, National Institutes of Health, Atlanta-Chamblee, Georgia.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 282 | 99 | 3 |
Full Text Views | 6 | 1 | 0 |
PDF Downloads | 2 | 1 | 0 |